If tirzepatide expiration and waste concern you, match your vial size to your weekly dose so each vial gets fully used within the stability window

Contraindications and Precautions Do NOT use AOD-9604 if you: Are pregnant, trying to conceive, or breastfeeding (no safety data in pregnancy/lactation) Have active cancer or history of malignancy (peptide effects on existing cancer unknown) Are under 18 years of age (pediatric safety not established) Have known hypersensitivity to peptides or benzyl alcohol (in bacteriostatic water) Have severe kidney or liver disease without physician clearance Use with caution and enhanced monitoring if you have: Diabetes or glucose metabolism disorders (monitor blood sugar closely despite no expected impact) Cardiovascular disease (comprehensive cardiac evaluation recommended) Thyroid disorders (monitor thyroid function during therapy) History of migraines (may increase headache frequency in susceptible individuals) Drug Interactions Limited formal drug interaction studies exist for AOD-9604
Ventrogluteal (hip) safe but harder to self-inject
Dosage & Administration: Administer as directed by a physician Typically given via IM or IV injection Frequency depends on severity of deficiency and patient condition Side Effects: Injection site pain or irritation Mild nausea Allergic reactions (rare) Flushing or dizziness (in some cases) Precautions: Use under medical supervision only Caution in patients with hypersensitivity to B vitamins Avoid overdose or prolonged unsupervised use Storage Instructions: Store below 25C Protect from light Keep out of reach of children
These cells carry oxygen
If you are experiencing side effects like muscle pain , fatigue , or anxiety , your reconstitution might not be the cause, but verifying your concentration and dose accuracy should be one of the first troubleshooting steps